Free Trial
NASDAQ:VIVE

Viveve Medical (VIVE) Stock Price, News & Analysis

Viveve Medical logo
$0.0003 0.00 (-70.00%)
(As of 12/20/2024 01:26 PM ET)

About Viveve Medical Stock (NASDAQ:VIVE)

Key Stats

Today's Range
$0.0003
$0.0004
50-Day Range
N/A
52-Week Range
$0.00
$0.04
Volume
7,330 shs
Average Volume
3,327 shs
Market Capitalization
$3,201.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Viveve Medical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence. The company offers Viveve System comprises of the radiofrequency generator, reusable handpiece, and treatment tip, as well as cryogen canister and other consumable components. It markets its products through sales employees and distributors in the United States, Canada, the Asia Pacific, Europe, the Middle East, Latin America, and internationally. Viveve Medical, Inc. was founded in 2005 and is headquartered in Englewood, Colorado.

Receive VIVE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Viveve Medical and its competitors with MarketBeat's FREE daily newsletter.

VIVE Stock News Headlines

Viveve Medical Inc (VIVE)
This is the worst sign for the U.S. stock market in 50 years
The Dow recently posted its worst losing streak since 1974. And one of America's most accurate analysts now says this is just the beginning of a new crisis that could be worse than the COVID crash, the dot-com crash, and even the Great Depression. Introducing "The Dead Zone"
Vaginal Rejuvenation Is Big Business
VIVE Viveve Medical, Inc.
See More Headlines

VIVE Stock Analysis - Frequently Asked Questions

Viveve Medical's stock was trading at $0.0002 at the beginning of 2024. Since then, VIVE shares have increased by 50.0% and is now trading at $0.0003.
View the best growth stocks for 2024 here
.

Viveve Medical, Inc. (NASDAQ:VIVE) released its quarterly earnings results on Thursday, November, 11th. The company reported ($0.67) earnings per share for the quarter, missing the consensus estimate of ($0.58) by $0.09. The company had revenue of $1.62 million for the quarter.

Viveve Medical (VIVE) raised $13 million in an initial public offering on Tuesday, June 14th 2016. The company issued 1,600,000 shares at a price of $8.00 per share. Ladenburg Thalmann and Craig-Hallum Capital Group served as the underwriters for the IPO and Maxim Group was co-manager.

Shares of VIVE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Viveve Medical investors own include Corbus Pharmaceuticals (CRBP), Visa (V), HP (HPQ), Fortive (FTV), Lowe's Companies (LOW), NIO (NIO) and Western Digital (WDC).

Company Calendar

Last Earnings
11/11/2021
Today
12/22/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Electromedical equipment
Sub-Industry
N/A
Current Symbol
NASDAQ:VIVE
Previous Symbol
OTCMKTS:PLCSD
Employees
47
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$6.83 million

Miscellaneous

Free Float
N/A
Market Cap
$3,201.00
Optionable
Not Optionable
Beta
0.71

Social Links

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for January 2025. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

This page (NASDAQ:VIVE) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners